Formula: | C21H25ClN6O2 |
Molecular Weight: | 428.92 |
Rotatable Bond Donors: | 6 |
clogP: | 2.15 |
Topological Polar Surface Area: | 120.16 |
Lipinski's RO5: | MW: 428.92 HBA: 8 HBD: 5 RB: 6 LogP: 2.15 |
Rule of Three: | MW: 428.92 HBA: 8 HBD: 5 RB: 6 LogP: 2.15 |
|
DB |
---|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC43204023 | 1.0 | ZINC43204023 RDKit 3D 30 33 0 0 0 0 0 0 0 0999 V2000 -1.1923 -1.8379 3.5151 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.2200 -1.5497 2.4617 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9373 -1.7522 1.1243 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9101 -2.8089 0.4918 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.6859 -0.6636 0.7244 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.4219 -0.6845 -0.5144 C 0 0 1 0 0 0 0 0 0 0 0 0 -3.5604 -1.6821 -0.4771 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3469 -2.7469 -1.5254 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5329 -2.1668 -2.8071 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.8963 0.6891 -0.8727 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9559 1.3035 -0.1982 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3625 2.5886 -0.5477 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7033 3.2603 -1.5717 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2027 4.8429 -2.0052 Cl 0 0 0 0 0 0 0 0 0 0 0 0 -2.6441 2.6642 -2.2488 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2411 1.3790 -1.8958 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2585 -0.1226 2.6643 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6062 0.1568 2.0369 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9635 -0.9068 1.1213 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0652 -0.5829 0.3180 C 0 0 0 0 0 0 0 0 0 0 0 0 4.0336 -1.5121 0.1014 N 0 0 0 0 0 0 0 0 0 0 0 0 5.0809 -1.2112 -0.6905 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3223 -0.0606 -1.3351 N 0 0 0 0 0 0 0 0 0 0 0 0 4.3433 0.8317 -1.1247 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2895 2.0866 -1.6628 N 0 0 0 0 0 0 0 0 0 0 0 0 3.1572 2.7301 -1.2533 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4648 1.8645 -0.4378 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2125 0.6583 -0.3367 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1039 -2.2201 1.7296 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9123 -2.5468 2.6088 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 3 5 1 0 5 6 1 0 6 7 1 1 7 8 1 0 8 9 1 0 6 10 1 0 10 11 2 0 11 12 1 0 12 13 2 0 13 14 1 0 13 15 1 0 15 16 2 0 2 17 1 0 17 18 1 0 18 19 1 0 19 20 1 0 20 21 2 0 21 22 1 0 22 23 2 0 23 24 1 0 24 25 1 0 25 26 1 0 26 27 2 0 27 28 1 0 19 29 1 0 29 30 1 0 30 2 1 0 16 10 1 0 28 20 1 0 28 24 2 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |